229 related articles for article (PubMed ID: 24025417)
1. Diagnostic and prognostic value of plasma microRNA deregulation in nasopharyngeal carcinoma.
Liu X; Luo HN; Tian WD; Lu J; Li G; Wang L; Zhang B; Liang BJ; Peng XH; Lin SX; Peng Y; Li XP
Cancer Biol Ther; 2013 Dec; 14(12):1133-42. PubMed ID: 24025417
[TBL] [Abstract][Full Text] [Related]
2. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.
Zhang H; Zou X; Wu L; Zhang S; Wang T; Liu P; Zhu W; Zhu J
Cancer Med; 2020 Feb; 9(3):1230-1241. PubMed ID: 31856390
[TBL] [Abstract][Full Text] [Related]
3. Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment.
Zhang G; Zong J; Lin S; Verhoeven RJ; Tong S; Chen Y; Ji M; Cheng W; Tsao SW; Lung M; Pan J; Chen H
Int J Cancer; 2015 Mar; 136(5):E301-12. PubMed ID: 25213622
[TBL] [Abstract][Full Text] [Related]
4. Five miRNAs as novel diagnostic biomarker candidates for primary nasopharyngeal carcinoma.
Tang JF; Yu ZH; Liu T; Lin ZY; Wang YH; Yang LW; He HJ; Cao J; Huang HL; Liu G
Asian Pac J Cancer Prev; 2014; 15(18):7575-81. PubMed ID: 25292031
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of miR-9 as a potential biomarker for nasopharyngeal carcinoma metastasis.
Lu J; Xu X; Liu X; Peng Y; Zhang B; Wang L; Luo H; Peng X; Li G; Tian W; He M; Li X
Br J Cancer; 2014 Jan; 110(2):392-8. PubMed ID: 24327016
[TBL] [Abstract][Full Text] [Related]
6. Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma.
Wen W; Mai SJ; Lin HX; Zhang MY; Huang JL; Hua X; Lin C; Long ZQ; Lu ZJ; Sun XQ; Liu SL; Yang Q; Zhu Q; Wang HY; Guo L
J Transl Med; 2019 Jun; 17(1):186. PubMed ID: 31159814
[TBL] [Abstract][Full Text] [Related]
7. A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma.
Liu N; Cui RX; Sun Y; Guo R; Mao YP; Tang LL; Jiang W; Liu X; Cheng YK; He QM; Cho WC; Liu LZ; Li L; Ma J
Int J Cancer; 2014 Mar; 134(6):1359-68. PubMed ID: 23999999
[TBL] [Abstract][Full Text] [Related]
8. miRNAs derived from circulating small extracellular vesicles as diagnostic biomarkers for nasopharyngeal carcinoma.
Jiang L; Zhang Y; Li B; Kang M; Yang Z; Lin C; Hu K; Wei Z; Xu M; Mi J; Wang R; Wu F
Cancer Sci; 2021 Jun; 112(6):2393-2404. PubMed ID: 33728743
[TBL] [Abstract][Full Text] [Related]
9. Plasma microRNA profiling in nasopharyngeal carcinoma patients reveals miR-548q and miR-483-5p as potential biomarkers.
Zheng XH; Cui C; Ruan HL; Xue WQ; Zhang SD; Hu YZ; Zhou XX; Jia WH
Chin J Cancer; 2014 Jul; 33(7):330-8. PubMed ID: 24874644
[TBL] [Abstract][Full Text] [Related]
10. Direct quantification of circulating miRNAs in different stages of nasopharyngeal cancerous serum samples in single molecule level with total internal reflection fluorescence microscopy.
Ho SL; Chan HM; Ha AW; Wong RN; Li HW
Anal Chem; 2014 Oct; 86(19):9880-6. PubMed ID: 25207668
[TBL] [Abstract][Full Text] [Related]
11. Plasma microRNA expression signature involving miR-548q, miR-630 and miR-940 as biomarkers for nasopharyngeal carcinoma detection.
Zhuo X; Zhou W; Li D; Chang A; Wang Y; Wu Y; Zhou Q
Cancer Biomark; 2018; 23(4):579-587. PubMed ID: 30475754
[TBL] [Abstract][Full Text] [Related]
12. Systematic comparison of plasma EBV DNA, anti-EBV antibodies and miRNA levels for early detection and prognosis of nasopharyngeal carcinoma.
Tan LP; Tan GW; Sivanesan VM; Goh SL; Ng XJ; Lim CS; Kim WR; Mohidin TBBM; Mohd Dali NS; Ong SH; Wong CY; Sawali H; Yap YY; Hassan F; Pua KC; Koay CE; Ng CC; Khoo AS;
Int J Cancer; 2020 Apr; 146(8):2336-2347. PubMed ID: 31469434
[TBL] [Abstract][Full Text] [Related]
13. Circulating miR-214-3p predicts nasopharyngeal carcinoma recurrence or metastasis.
Wang J; Xu Y; Wang J; Ying H
Clin Chim Acta; 2020 Apr; 503():54-60. PubMed ID: 31926154
[TBL] [Abstract][Full Text] [Related]
14. miR-29a/b enhances cell migration and invasion in nasopharyngeal carcinoma progression by regulating SPARC and COL3A1 gene expression.
Qiu F; Sun R; Deng N; Guo T; Cao Y; Yu Y; Wang X; Zou B; Zhang S; Jing T; Ling T; Xie J; Zhang Q
PLoS One; 2015; 10(3):e0120969. PubMed ID: 25786138
[TBL] [Abstract][Full Text] [Related]
15. Circulating miR-31-5p may be a potential diagnostic biomarker in nasopharyngeal carcinoma.
Yi SJ; Liu P; Chen BL; Ou-Yang L; Xiong WM; Su JP
Neoplasma; 2019 Sep; 66(5):825-829. PubMed ID: 31129965
[TBL] [Abstract][Full Text] [Related]
16. Circulating Epstein-Barr virus microRNAs BART7-3p and BART13-3p as novel biomarkers in nasopharyngeal carcinoma.
Lu T; Guo Q; Lin K; Chen H; Chen Y; Xu Y; Lin C; Su Y; Chen Y; Chen M; Zheng Y; Ye Y; Lin S; Zong J; Pan J
Cancer Sci; 2020 May; 111(5):1711-1723. PubMed ID: 32155300
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus mir-bart1-5p detection via nasopharyngeal brush sampling is effective for diagnosing nasopharyngeal carcinoma.
Zheng XH; Lu LX; Cui C; Chen MY; Li XZ; Jia WH
Oncotarget; 2016 Jan; 7(4):4972-80. PubMed ID: 26701721
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA expression profiling analysis in serum for nasopharyngeal carcinoma diagnosis.
Zou X; Zhu D; Zhang H; Zhang S; Zhou X; He X; Zhu J; Zhu W
Gene; 2020 Feb; 727():144243. PubMed ID: 31743768
[TBL] [Abstract][Full Text] [Related]
19. Methods and matrices: approaches to identifying miRNAs for nasopharyngeal carcinoma.
Plieskatt JL; Rinaldi G; Feng Y; Levine PH; Easley S; Martinez E; Hashmi S; Sadeghi N; Brindley PJ; Bethony JM; Mulvenna JP
J Transl Med; 2014 Jan; 12():3. PubMed ID: 24393330
[TBL] [Abstract][Full Text] [Related]
20. Serum miRNAs, a potential prognosis marker of loco-regionally advanced nasopharyngeal carcinoma patients treated with CCRT.
Zhang Z; Huang J; Wang G; Jin F; Zheng J; Xiao H; Lei L; Luo J; Chen C
BMC Cancer; 2020 Mar; 20(1):183. PubMed ID: 32131777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
